KRISPY KREME INC (DNUT) Fundamental Analysis & Valuation

NASDAQ:DNUT • US50101L1061

Current stock price

3.23 USD
-0.19 (-5.56%)
At close:
3.25 USD
+0.02 (+0.62%)
After Hours:

This DNUT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DNUT Profitability Analysis

1.1 Basic Checks

  • DNUT had negative earnings in the past year.
  • In the past year DNUT had a positive cash flow from operations.
  • DNUT had negative earnings in 4 of the past 5 years.
  • In the past 5 years DNUT always reported a positive cash flow from operatings.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

1.2 Ratios

  • The Return On Assets of DNUT (-20.06%) is worse than 93.65% of its industry peers.
  • With a Return On Equity value of -80.00%, DNUT is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -20.06%
ROE -80%
ROIC N/A
ROA(3y)-7.04%
ROA(5y)-4.48%
ROE(3y)-27.65%
ROE(5y)-17.26%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • DNUT's Gross Margin of 28.98% is on the low side compared to the rest of the industry. DNUT is outperformed by 78.57% of its industry peers.
  • In the last couple of years the Gross Margin of DNUT has remained more or less at the same level.
  • DNUT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

0

2. DNUT Health Analysis

2.1 Basic Checks

  • DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DNUT has been increased compared to 1 year ago.
  • Compared to 5 years ago, DNUT has more shares outstanding
  • The debt/assets ratio for DNUT is higher compared to a year ago.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • DNUT has an Altman-Z score of 0.13. This is a bad value and indicates that DNUT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of DNUT (0.13) is worse than 85.71% of its industry peers.
  • DNUT has a Debt/Equity ratio of 1.40. This is a high value indicating a heavy dependency on external financing.
  • DNUT has a Debt to Equity ratio (1.40) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACC6.96%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • DNUT has a Current Ratio of 0.38. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DNUT has a worse Current ratio (0.38) than 86.51% of its industry peers.
  • A Quick Ratio of 0.32 indicates that DNUT may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.32, DNUT is not doing good in the industry: 84.13% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.32
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

3

3. DNUT Growth Analysis

3.1 Past

  • DNUT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -183.33%.
  • DNUT shows a decrease in Revenue. In the last year, the revenue decreased by -8.57%.
  • DNUT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.30% yearly.
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)-8.57%
Revenue growth 3Y-0.16%
Revenue growth 5Y6.3%
Sales Q2Q%-2.88%

3.2 Future

  • Based on estimates for the next years, DNUT will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.42% on average per year.
  • The Revenue is expected to grow by 7.09% on average over the next years.
EPS Next Y31.83%
EPS Next 2Y37.62%
EPS Next 3Y-23.24%
EPS Next 5Y12.42%
Revenue Next Year-1.42%
Revenue Next 2Y0.93%
Revenue Next 3Y2.16%
Revenue Next 5Y7.09%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2030 0 0.2 0.4

0

4. DNUT Valuation Analysis

4.1 Price/Earnings Ratio

  • DNUT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year DNUT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DNUT is valued a bit more expensive than 65.87% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

  • A cheap valuation may be justified as DNUT's earnings are expected to decrease with -23.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.62%
EPS Next 3Y-23.24%

5

5. DNUT Dividend Analysis

5.1 Amount

  • DNUT has a Yearly Dividend Yield of 4.09%, which is a nice return.
  • The stock price of DNUT dropped by -24.53% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • DNUT's Dividend Yield is rather good when compared to the industry average which is at 1.10. DNUT pays more dividend than 92.06% of the companies in the same industry.
  • DNUT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 4.09%

5.2 History

  • DNUT has been paying a dividend for over 5 years, so it has already some track record.
  • DNUT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • The earnings of DNUT are negative and hence is the payout ratio. DNUT will probably not be able to sustain this dividend level.
DP-2.29%
EPS Next 2Y37.62%
EPS Next 3Y-23.24%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

DNUT Fundamentals: All Metrics, Ratios and Statistics

KRISPY KREME INC

NASDAQ:DNUT (3/27/2026, 8:12:19 PM)

After market: 3.25 +0.02 (+0.62%)

3.23

-0.19 (-5.56%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners43.66%
Inst Owner Change1.24%
Ins Owners3.23%
Ins Owner Change0.04%
Market Cap556.21M
Revenue(TTM)1.52B
Net Income(TTM)-520.07M
Analysts52.31
Price Target4.62 (43.03%)
Short Float %25.73%
Short Ratio8.11
Dividend
Industry RankSector Rank
Dividend Yield 4.09%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP-2.29%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.6%
Min EPS beat(2)118.57%
Max EPS beat(2)184.63%
EPS beat(4)2
Avg EPS beat(4)-12.9%
Min EPS beat(4)-353.46%
Max EPS beat(4)184.63%
EPS beat(8)3
Avg EPS beat(8)-41%
EPS beat(12)5
Avg EPS beat(12)-31.81%
EPS beat(16)7
Avg EPS beat(16)-25.64%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-0.53%
Revenue beat(4)0
Avg Revenue beat(4)-2.28%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)-0.53%
Revenue beat(8)0
Avg Revenue beat(8)-2.13%
Revenue beat(12)2
Avg Revenue beat(12)-1.67%
Revenue beat(16)4
Avg Revenue beat(16)-1.42%
PT rev (1m)4.47%
PT rev (3m)5.99%
EPS NQ rev (1m)8.74%
EPS NQ rev (3m)8.74%
EPS NY rev (1m)27.98%
EPS NY rev (3m)36.95%
Revenue NQ rev (1m)-6.39%
Revenue NQ rev (3m)-6.7%
Revenue NY rev (1m)0.92%
Revenue NY rev (3m)-2.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF 16.4
P/B 0.86
P/tB N/A
EV/EBITDA 16
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)0.2
OCFY6.1%
SpS8.84
BVpS3.78
TBVpS-4.99
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.06%
ROE -80%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.98%
FCFM N/A
ROA(3y)-7.04%
ROA(5y)-4.48%
ROE(3y)-27.65%
ROE(5y)-17.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-0.06%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF N/A
Debt/EBITDA 9.78
Cap/Depr 71.44%
Cap/Sales 6.43%
Interest Coverage N/A
Cash Conversion 36.4%
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.32
Altman-Z 0.13
F-Score5
WACC6.96%
ROIC/WACCN/A
Cap/Depr(3y)86.1%
Cap/Depr(5y)95.44%
Cap/Sales(3y)6.96%
Cap/Sales(5y)7.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y31.83%
EPS Next 2Y37.62%
EPS Next 3Y-23.24%
EPS Next 5Y12.42%
Revenue 1Y (TTM)-8.57%
Revenue growth 3Y-0.16%
Revenue growth 5Y6.3%
Sales Q2Q%-2.88%
Revenue Next Year-1.42%
Revenue Next 2Y0.93%
Revenue Next 3Y2.16%
Revenue Next 5Y7.09%
EBIT growth 1Y-248.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.81%
EBIT Next 3Y37.63%
EBIT Next 5Y24.32%
FCF growth 1Y14.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.98%
OCF growth 3Y-37.63%
OCF growth 5Y3.4%

KRISPY KREME INC / DNUT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KRISPY KREME INC (DNUT) stock?

ChartMill assigns a fundamental rating of 1 / 10 to DNUT.


Can you provide the valuation status for KRISPY KREME INC?

ChartMill assigns a valuation rating of 0 / 10 to KRISPY KREME INC (DNUT). This can be considered as Overvalued.


Can you provide the profitability details for KRISPY KREME INC?

KRISPY KREME INC (DNUT) has a profitability rating of 1 / 10.


What is the earnings growth outlook for KRISPY KREME INC?

The Earnings per Share (EPS) of KRISPY KREME INC (DNUT) is expected to grow by 31.83% in the next year.